Here, the responses of mammalian and mosquito cell lines, in addition to primary human fetal astrocytes and neurons were studied following infection by ZIKV strains Brazil 2016 (ZIKV-BR), French Polynesia 2013 (ZIKV-FP), and Uganda #976 1947 (ZIKV-UG). Viral production, cell viability, infectivity rate, and mobility of endocytotic ZIKV-laden vesicles were compared. All cell types (SK-N-SH, Vero E6, C6/36, human fetal astrocytes and human fetal neurons) released productive virus. Among primary cells, astrocytes were more susceptible to ZIKV infection than neurons, released more progeny virus and tolerated higher virus loads than neurons. In general, the infection rate of ZIKV-UG strain was the highest. All ZIKV strains elicited differences in trafficking of ZIKV-laden endocytotic vesicles in the majority of cell types, including astrocytes and neurons, except in mosquito cells, where ZIKV infection failed to induce cell death. These results represent a thorough screening of cell viability, infection and production of three ZIKV strains in five different cell types and demonstrate that ZIKV affects vesicle mobility in all but mosquito cells.
Results
During the ZIKV epidemics in Micronesia (2007) , French Polynesia (FP, 2013 (FP, -2014 , other South Pacific islands (2014) (2015) , and in Latin America and the Caribbean (BR, 2015-2016), strains originating from the Asian ZIKV lineage were found circulating in the human population 1, 2 . Here, we used two Asian-lineage ZIKV strains ZIKV-FP (2013) and ZIKV-BR (2016), which are responsible for the latest international outbreaks causing neuropathology 13 , and the African lineage ZIKV-UG #976 (1947) , to test their infectivity rate, release, effects on cell viability, cytopathologic effects (CPE), and the mobility of ZIKV-laden endocytotic vesicles in mammalian (SK-N-SH and Vero E6) and mosquito (C6/36) cell lines, as well as in human fetal astrocytes and neurons.
The infectious virus production in mammalian cell lines is similar to mosquito cell line that resist ZIKV-Triggered cell death. First we assessed ZIKV infection kinetics in selected mammalian
SK-N-SH and Vero E6 plus C6/36 mosquito cell lines. The increase in infectious virus production was measured at an MOI 0.1 after several hours post infection (12, 18, 24, 36, 48, 60, 72 , and 84 hpi). Productive ZIKV replication of strains ZIKV-BR and ZIKV-UG in the form of released infectious virions was detected at 18 hpi, while the productive replication of ZIKV-FP was delayed in all cell lines ( Fig. 1a i ) . The reproducible plaque counts in all three cell lines were observed at earliest at 18 hpi, however, at 84 hpi there was no significant difference in the concentration of infectious viral particles among different strains ( Fig. 1a i ) . In general, viral titers of all three ZIKV strains reached approximately 10 6 plaque forming units (pfu)/ml in the culture medium after 72 hpi in all cell lines and remained high until the end of the experiment at 84 hpi. At 18 hpi a few plaques were produced by ZIKV-FP; however, their number was too low to accurately determine the virus titer.
Then we tested how the infectious virus production affects cell viability. We determined cell viability by two different assays; Reliablue cell viability reagent, measuring metabolic activity of living cells (Fig. 1b i ,c i ), and with trypan blue exclusion assay (Fig. S1 ). As shown in Fig. 1b i ,c i , the survival of mammalian cell lines, infected with ZIKV strains at an MOI 0.1 (Fig. 1b i ) and MOI 1 (Fig.1c i ) , were severely affected. Both mammalian cell lines, SK-N-SH and Vero E6, show somewhat similar rate of decline in cell survival at the same MOI. Among ZIKV strains it appears that ZIKV-UG affected the viability of SK-N-SH cells more than the other two strains at both tested MOIs, while in Vero E6 cells ZIKV-BR affected the viability more than ZIKV-UG and ZIKV-FP at an MOI 0.1, while at an MOI 1 only ZIKV-FP was less detrimental for cell survival. The viability of mosquito C6/36 cells was unaffected by ZIKV infection ( Fig. 1b i ,c i ). The survival rate of cell lines measured with Reliablue reagent was higher from the one measured with trypan blue exclusion assay ( Fig. S1 ), however, all the trends remained the same. Although the same number of cells and the same MOI (0.1) was used in both viability tests, certain differences between the two methods may be accounted to errors that may occur for instance due to poor dispersion of cells and cell loss during cell dispersion with Countess Automated Cell Counter counting. On the other hand, Reliablue Cell Viability Assay, though not error-free (e.g. possible high background in control wells), appears to be more reliable.
In general, the increase in viral production was correlated with the decrease in cell survival, except for the mosquito cells, which were resilient to ZIKV infection (Fig. 1) . The time point at which the virus concentration in the supernatant reached maximal levels corresponded well with the decline in viability of all cell types (except the mosquito cell line).
Human fetal astrocytes have higher infectious virus production and tolerate ZIKV infection better than human fetal neurons. To determine cell responses of human astrocytes and neurons to infection
with selected ZIKV strains, we performed measurements of infectious viral particle production and viability of host cells, as described for cell lines. At 12 hpi we have already detected the increase in viral RNA ( Fig. S1 ), but infectious viral particles, collected in the supernatant at this time point did not produce countable plaques ( Fig. 1a ii ). Higher quantity of infectious viral particles was observed in astrocytes (over 6-logarithmic units), further implying that astrocytes are an important source of infectious virus in the brain. On the other hand, the production of infectious virus was the lowest in neurons, where only 2-logarithmic units increase was observed ( Fig. 1a ii ). Thus, human neurons appear to be the poorest ZIKV producers among the cells tested. Additionally, we detected a difference between the growth rates among the three ZIKV strains in astrocytes and neurons, respectively. However, the overall production of ZIKV strains was lower in neurons than in astrocytes and ZIKV-FP in particular increased marginally over time in neurons. Similarly, as measured in cell lines, strains ZIKV-BR and ZIKV-UG induced the formation of the first plaques at 18 hpi, ZIKV-FP production was the slowest of all strains and there was also no significant difference in the production of infectious viral particles among the three strains at 84 hpi.
To study the effect of infectious virus production on cell viability, we infected cells with two different MOI (0.1 and 1) and measured cell survival. Both, astrocytes and neurons, survived better when they were infected at an MOI 0.1 (Fig. 1b ii ) than at an MOI 1 (Fig. 1c ii ). The viability of neurons was affected more than that of astrocytes. Roughly half of astrocytes were still viable at 84 hpi (MOI 0.1, ZIKV-BR, ZIKV-UG), when measured with Reliablue Cell Viability Assay. Measuring the cell survival with trypan blue exclusion assay produced slightly lower yields ( Fig. S1 ), as observed for cell lines. At both MOI (0.1 and 1) ZIKV-FP affected cell viability of astrocytes less than ZIKV-BR and ZIKV-UG, similar as in VERO E6 cells. In neurons we did not observe any difference among strains in respect of cell survival.
Taken together, astrocytes showed similar infectious virus production as cell lines, but higher than neurons. Faster ZIKV production, especially considering the fact that astrocytes are at least as numerous as neurons 38 , speaks in favour of the hypothesis that human astrocytes are the major cell source for the spread of ZIKV through the fetal CNS. www.nature.com/scientificreports www.nature.com/scientificreports/ Different cell types show different infection rates with ZIKV; ZIKV-UG has the highest infection rate in all cell types. Once virions are adhered to the cell membrane, the virus relocates along the cell surface until it is recognized by specific binding or internalization receptors 39 . After receptor-mediated endocytosis, virions travel through the cytoplasm into which they are released to begin their replication cycle 40 . We addressed the question whether different cell types differ in the infection rate and if the infection rates are strain-specific.
Cells were infected at an MOI 0.1 and immunolabeled against flavivirus group antigen antibodies. The infection rates in cell lines SK-N-SH, Vero E6 and C6/36 were low at 12 hpi in all three ZIKV strains tested ( Fig. 2) . While in SK-N-SH cells the percentages of infected cells with different ZIKV strains were similar, ZIKV-UG had significantly higher infection rate than ZIKV-BR in Vero E6 cells, and ZIKV-BR and ZIKV-UG infected significantly higher percentage of C6/36 cells than ZIKV-FP (ANOVA, p < 0.05). On the other hand, significantly higher infection rates were detected at 84 hpi, when compared to infection after 12 hpi (Mann-Whitney test; p < 0.001). ZIKV-UG induced the highest infection rates at 84 hpi in all cell lines; the highest percentage was measured in Vero E6 cells, where almost all cells were infected (Fig. 2) .
In human fetal astrocytes the infection rates at 12 hpi were significantly higher than in cell lines studied (ANOVA, p < 0.05; Figs 2 and 3). At this time point, ZIKV-BR and ZIKV-UG infected significantly more astrocytes than ZIKV-FP (ANOVA, p < 0.05). At 84 hpi the percentages of infected cells were significantly higher, compared to those at 12 hpi (Mann-Whitney test; p < 0.001), however, they were lower than in cell lines at 84 hpi (ANOVA, p < 0.05; Fig. 2 ). Similarly, as at 12 hpi, also at 84 hpi ZIKV-BR and ZIKV-UG strains infected significantly more astrocytes than ZIKV-FP ( Fig. 3) . The lowest infection rates after 12 hpi were measured in human fetal neurons and they remained low after 84 hpi ( Fig. 3 ). While there were no differences among infection rates of ZIKV strains at 12 hpi, ZIKV-UG infected significantly more neurons at 84 hpi than ZIKV-FP and ZIKV-BR ( Fig. 3 ). To ascertain the purity of astrocyte and neuronal cultures we immunolabeled them with antibodies against astrocyte marker GFAP and neuronal marker βIII Tubulin. The results revealed that 99.3 ± 0.3% of astrocytes and 98.3 ± 0.5% of neurons were positive for respective markers (means ± SEM).
In summary, these data show that ZIKV-UG strain infected significantly more cells in the majority of cell types studied. Among five cell types tested, astrocytes showed the highest initial infection rate, while Vero E6 were the most susceptible to ZIKV infection, judging from the results at 84 hpi. Among human primary cells isolated from neural tissue, astrocytes were considerably more permissive for ZIKV infection than neurons. The difference was obvious already at 12 hpi, and increased further at 84 hpi.
Increase in ZIKV-Laden vesicle mobility was observed in ZIKV-BR and ZIKV-UG strains. Upon
internalization into the host cell, flaviviruses, including ZIKV, reside at first in endosomes 11, [41] [42] [43] . As for their internalization, and for their delivery to replication sites, assembly, and egress, viruses use the host cytoskeleton, eventually also causing rearrangements of the cytoskeleton filaments 44 . The latter, for example, have been observed in flavivirus-infected medulloblastoma, glioblastoma, and primary astrocytes 36, 45 . While still unclear, the interaction between the virus and the cytoskeleton may affect virus traffic from the plasma membrane. To test whether ZIKV strains can affect the mobility of endocytotic vesicles by which they are transported, we measured the movement of ZIKV-laden vesicles and determined the travel length (TL), net maximal displacement (MD) of vesicles and their speed. We infected cells with DiD-labeled ZIKV strains (DiD-ZIKV) and checked if the mobility of endosomes was affected after 12, 36, and 84 hpi. Inside the cells, DiD-ZIKV aggregated into vesicular structures in astrocytes and neurons (Fig. 4a ). The vast majority of these intracellular fluorescent vesicular structures contained DiD-ZIKV particles and not unspecific DiD dye, that was confirmed by co-labeling with the ZIKV-antibody-positive patient's serum (Fig. 4a ). The trajectories of vesicle movements in astrocytes and neurons are represented in Fig. 4b-d . Interestingly, in astrocytes we observed differences in mobility parameters depending on the ZIKV strain ( Fig. 4d ). While the speed of endocytotic ZIKV-laden vesicles after 12 hpi was similar or slightly higher in comparison to the speed of endocytotic vesicles in uninfected, unstimulated, astrocytes 28, 30, 31, [46] [47] [48] , later during the infection changes in the vesicle speed were noticed. Endocytotic vesicles loaded with ZIKV-BR or ZIKV-UG became more mobile as a function of time; TL, MD, and speed were significantly increased (Figs 4d and 5) after prolonged infection. In contrast, vesicles carrying ZIKV-FP showed progressively more confined and slower movements during the infection period; their mobility almost halved by the end of the experiment (Figs 4d and 5 ). In neurons, vesicles laden with ZIKV strains showed increased mobility at 84 hpi versus 12 hpi (Figs 4e and 5). ZIKV-FP-and ZIKV-UG-laden vesicles showed decreased mobility as a function of hpi only in neuronal processes (Fig. S3 ). In contrast, in mosquito C6/36 cells, in which ZIKV infection did not compromise survival, the trafficking dynamics of ZIKV-laden vesicles remained unaltered throughout the experiment ( Fig. 6 ). In these cells, the intracellular signal of internalized ZIKV particles differed compared with other cell types; it was predominantly diffused with scattered assemblies of vesicular structures (Fig. 6) .
In short, similarly as different ZIKV strains showed different replication dynamics in the course of the experiments ( Fig. 1) , we observed that different ZIKV strains also differentially affected trafficking of ZIKV-laden vesicles, an effect that was especially pronounced in astrocytes.
In addition, we analyzed vesicle trafficking of ZIKV-laden endocytotic vesicles in control cells that were used for viral amplification. SK-N-SH derived from neuroblasts in embryo or fetus 49 , Vero E6 cells and especially mosquito C6/36 cells display striking differences in response to ZIKV infection in comparison with astrocytes and neurons. In SK-N-SH and Vero E6 cells decreased mobility of endocytotic ZIKV-laden vesicles toward the end of the experiment was observed (Figs S1 and S2), while in mosquito C6/36 cells the mobility parameters were constant during the experiment.
In summary, we compared the effects of infection of the Asian-lineage ZIKV strains ZIKV-BR and ZIKV-FP; and the African-lineage strain ZIKV-UG on selected cell types. The results revealed resistance of astrocytes to ZIKV-induced cell death, considering their role in massive production of ZIKV versus neurons. Neurons proved www.nature.com/scientificreports www.nature.com/scientificreports/ to be the poorest producers of all ZIKV strains. In the majority of cell types, the infection rate of ZIKV-UG strain was the highest. All ZIKV strains triggered differences in trafficking of ZIKV-laden endocytotic vesicles in practically all cell types studied, except in mosquito cells, where ZIKV infection failed to induce cell death.
Discussion
Motivated by the latest ZIKV outbreak, interest in the effects of ZIKV infection on neuronal cells, especially in the prenatal stage, has increased considerably. Several studies have addressed the issue of which cells are predominantly affected in the fetal brain. It has been shown that ZIKV infects human NPCs, NSCs, RGCs, microglial cells, oligodendrocyte precursor cells, neurons, and astrocytes 10, 11, 13, 19, 50 . However, it is unclear how infected fetal neuronal cells respond to infection with different ZIKV strains. The focus of our study was, therefore, to compare www.nature.com/scientificreports www.nature.com/scientificreports/ the responses of primary human fetal astrocytes and neurons to infection with low passages of the Asian-lineage strains ZIKV-BR and ZIKV-FP, and of the African-lineage strain ZIKV-UG. We also compared the responses to ZIKV infection from human astrocytes and neurons with the responses from several cell lines.
The first conclusion of this study is that astrocytes are initially more, but in the long term less susceptible to ZIKV infection than the selected mammalian and mosquito cell lines. However, astrocytes are more susceptible to ZIKV infection than neurons, as determined by the percentage of infected cells after infection with the ZIKV. On the other hand, astrocytes production of the virus was comparable to the amount produced in the selected cell lines. Considering that the production of infectious virus particles was much higher in astrocytes and their viability at least as high as in neurons, this indicates that astrocytes can tolerate higher amount of the virus load compared to neurons. The higher susceptibility of human astrocytes versus neurons is in line with the observation that ZIKV strains Cambodia (2010), Brazil (2015), and Puerto Rico (2015) infected more RGCs and astrocytes in cortical tissue slices than post-mitotic neurons in a period from early gestation to around mid-gestation 19 . Our findings further support this observation by revealing that the infection rate of ZIKV is lower in human neurons than in astrocytes. Our observation of low infection rate in human fetal astrocytes is also in line with data obtained in mice astrocytes and human adult astrocytes 51, 52 . Higher infection rates in astrocytes versus neurons, regardless of the strain, reflect the differences detected in the extent and/or the types of ZIKV entry receptors described in both cell types 20 . Namely, astrocytes at mid-gestation abundantly express Axl, a type of TAM entry receptor, while NPCs and neurons poorly express Axl 20 . Higher ZIKV uptake into neurons after prolonged hpi in our experiments may indicate that infection further promotes viral entry, which in vivo is most likely promoted by astrocytic hyper-production of ZIKV. In line with this conclusion, we observed differences not only in the infection rate between astrocytes and neurons, but also differences in the productive virus release rate for the two cell types. It appears that in neurons, virus production and release were suppressed with prolonged infection. The fact that astrocytes apparently did not suppress virus production and proved to be much more resilient to the higher among of infectious virus particles supports the view that astrocytes are the major producer of ZIKV progeny in the brain. It is to be expected that when astrocytes become infected, massive infection of other CNS cell types will follow. From this perspective, it is of outmost importance to prevent the infection of astrocytes. This was shown to be successful with azithromycin, which reduced the infection, rescued cell viability, and decreased viral production in U87 cell lines and human pluripotent stem cell-derived astrocytes 19 .
While astrocytes are massively infected by the ZIKV strains and they vigorously produce ZIKV, they appear to be more resistant to ZIKV-induced cell death. Cell survival data of astrocytes are similar to the observation from another study where cell survival of human fetal astrocytes decreased to similar levels after 4 days post infection, however, it is noteworthy that a large proportion of astrocytes remained viable 53 . One has to be careful when comparing different viability data of human astrocytes, since there is some variability among different sources, different donors and different strains [53] [54] [55] . Astrocytes appear to be important reservoirs of ZIKV and thus are compelling targets for next-generation drug therapies. Certain pool of human fetal astrocytes can even establish persistent infection with ZIKV, further supporting the theory that these cells can serve as a reservoir for ZIKV persistence in the fetal brain 53 .
When looking at the level of different strains, it is obvious that the infection rate of ZIKV-UG was the highest in practically all cell types tested, except in human fetal astrocytes where infection rate of ZIKV-BR was similar. This observation is slightly different from the observation in human adult astrocytes, where at an MOI 0.1 African ZIKV strain infected more cells than Brasil ZIKV strain 52 . Lower infection rates at longer times post infection of ZIKV strains in astrocytes versus SK-N-SH, Vero E6 and C6/36 cells can reflect several possibilities; for example the difference in the amount of AXL surface receptor that was shown to be lower in astrocytes than in human lung carcinoma cell line 53 , or the ability of astrocytes to induce rapid upregulation of type I IFNs and thereby restricting viral replication and spread 51 . The function of Axl receptor is still debated, as whether it functions as ZIKV entry receptor or if it promotes ZIKV infection in human astrocytes by antagonizing type I IFN signaling 56 . In addition to that, virus strain itself may affect cell infection rate, as we observed in the case of ZIKV-FP, where cell infection rate was the lowest among all strains in the majority of cell types tested. Moreover, ZIKV-BR and ZIKV-UG initiated production and release of infectious virus particles more rapidly than ZIKV-FP. This finding is similar to the results of another study, in which ZIKV-FP was reported to infect a lower number of astrocytes than an ArB41644 ZIKV strain of African lineage (Bangui, Central African Republic, 1989), had lower production, and induced milder cell death 13 . Moreover, recent study showed significant differences in the growth properties of ZIKV fetal brain isolate FB-GWUH-2016 and ZIKV-FP in different cell types 57 .
In addition to the differences between strains regarding their production rate and infection, we have identified a novel property in their effect on endocytotic trafficking that differs between ZIKV strains. Whereas ZIKV-BR and ZIKV-UG strains on average enhanced endocytotic vesicle mobility in astrocytes and neurons, ZIKV-FP-laden vesicles decreased their mobility, especially in astrocytes. It remains to be highlighted in detail how specific ZIKV strains, and other flaviviruses, i.e. TBEV 36 , manipulate the trafficking machinery of endocytotic vesicles. In general, endocytotic transport can be altered by different expression of cytoskeleton proteins, Rab and Rho GTPases that regulate intracellular trafficking, and actin and microtubule assembly 36, [44] [45] [46] 58 . Viruses hijack a number of proteins that enable intracellular vesicle trafficking, such as actin, tubulin, dynamin, and Rho GTPases, and by their manipulation, they may alter the mobility of vesicles 44, 59, 60 . In addition to subverting host cell proteins, viruses also alter lipid signaling mechanisms that are responsible for entry, replication, nuclei representing single cells). Cells were counted in twelve separate fields of view for each cell type (The number of cells counted per strain: 414 astrocytes and 4287 neurons), data were collected from one experiment performed in duplicates (10 4 cells plated per sample). www.nature.com/scientificreports www.nature.com/scientificreports/ egress and trafficking of virions in the host cell 39, [61] [62] [63] [64] [65] [66] . ZIKV strains may manipulate endocytotic trafficking differently through rearrangement of the cytoskeleton (as e.g., after TBEV infection) or at the transcriptional level with the upregulation of cytoskeleton-linked proteins (actin, tubulin, dynamin, and Rho GTPases) as was shown for West Nile virus 36, 45, 59 . Moreover, a recent study showed that genes involved in the regulation of intracellular vesicle-mediated transport are differentially expressed in human peripheral neurons infected with ZIKV strain from the 2015 Puerto Rico Zika outbreak 61 . It is hypothesized that the altered abundance of cytoskeletal proteins may participate in viral particle assembly, cargo, and egress, leading to the replication and release of mature virions 59 .
In conclusion, this study highlights the potential of astrocytes to be the main ZIKV source in the CNS, as they massively produce and release ZIKV, and are resilient to a high virus production. Neurons, on the other hand, appear to suppress the production of virus and also have lower infection rates. Variabilities among different ZIKV strains are visible at several steps of the viral cycle, such as different production and infection rates, infection and trafficking of endocytotic ZIKV-laden vesicles. Future studies are needed to highlight the strain-specific relationships between the cytoskeleton and altered vesicle trafficking.
Methods
Cell cultures. Human fetal cortical astrocytes (20 gw) were obtained from Innoprot (Derio, Spain). They were cryopreserved at passage one and checked for cell culture purity by GFAP immunofluorescent staining by the provider prior to shipment. Upon delivery they were grown for one passage (4 days) in cell-culture flasks and plated onto chambered coverslips (µ-Slide 2 Well; Ibidi, Martinsried) for use in the experiments within the following three days. They were maintained in complete astrocyte medium (Innoprot) at 37 °C in 5% CO 2 .
Human fetal neurons (20 gw), cryopreserved immediately after tissue dissociation, at passage 0 (P0), were acquired from Innoprot (Spain). Neurons were thawed and plated directly onto poly-D-lysine (Sigma)-coated chambered coverslips (µ-Slide 2 Well; Ibidi, Germany) for use in the experiments within the following three days. They were maintained in complete neuronal medium (Innoprot) at 37 °C in 5% CO 2 /95% air.
Human neuroblastoma, SK-N-SH (ATTC HTB-11), and African green monkey kidney cells, Vero E6 cells (ATTC CRL-1586), were grown in DMEM GlutaMAX (DMEM with GlutaMAX Supplement; Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific) at 37 °C in 5% CO 2 .
Mosquito Aedes albopictus, C6/36 cells 67 (kindly provided by Dr. David H. Walker, University of Texas Medical Branch, Department of Pathology, Galveston, Texas, USA), were grown in Leibovitz's L-15 medium with GlutaMAX supplemented with 10% FBS at 28 °C.
ZIKV Strains and cellular infection. ZIKV strains #976 (historical strain, isolated in 1947 in Uganda;
passaged 3 × in baby mouse brain, then lyophilised in 1961; ZIKV-UG), H/PF/2013 (isolated from patient's serum from the French Polynesia outbreak in 2013; ZIKV-FP; the strain was obtained from the EVAg collection no.001 V-EVA1545 (UMR 190-Unite Des Virus Emergentes, Marseille, France, five passages on Vero E6 cells), and BR/800/16 (isolated in Slovenia from patient returning from Brazil in May 2016; ZIKV-BR) 4, 68, 69 . Before the experiment, all strains were propagated in Vero E6 in DMEM GlutaMAX with 4% FBS to prepare virus stocks: ZIKV-UG, three passages; ZIKV-BR, three passages; ZIKV-FP, two passages. After harvesting the virus, the cell suspension was centrifuged at 4 °C/1,000 × g for 5 min and the supernatant was collected into aliquots.
For the experiments, all cells were plated onto two-chambered coverslips (µ-Slide 2 Well; Ibidi, Germany, Martinsried) 48 h before infection with ZIKV strains (unlabeled and DiD-labeled) at an MOI of 0.1. Before inoculation, cells were washed twice with sterile PBS, and ZIKV was added to the cells in a low medium volume (600 µL). ZIKV was allowed to adsorb to an 80% confluent cell monolayer for 1 h at 37 °C or 28 °C (C6/36). Following adsorption, the monolayers were washed with PBS twice and grown in fresh growth medium. Control samples were incubated with the corresponding culture growth media (mock condition). Supernatants for RT-qPCR and plaque assay were collected at 12, 18, 24, 36, 48, 60, 72 , and 84 h post infection (hpi), and cell viability was assessed either with a trypan blue exclusion test on Countess Automated Cell Counter (Invitrogen) or a Reliablue Cell Viability Reagent (ATCC 30-1014) that measures cell metabolic activity. In brief, cells were plated at the concentration of 10 4 cells/100 μl/well in a 96 well plate, 24 h before inoculation. At each inoculation time point (12, 18, 24, 36, 48, 60, 72 , and 84 h) the medium was removed, cells were washed with PBS twice, and 100 µL of the virus was inoculated. At 84 h post infection 10 µL of Reliablue reagent was added with a multichannel pipet. After 1 h incubation at 37 °C (or 28 °C for C6/36) a fluorescent signal (excited at 540 nm and emission gathered at expanded in (d). Scale bars, 5 µm. (d) Vesicle trajectories of the two typical trajectories noted in all cells types. The nearly straight trajectory of vesicle 1 depicts the highly directional movement of a vesicle. Travel length (TL) is similar in distance as the maximal displacement (MD) of a vesicle. The contorted trajectory of vesicle 2 depicts non-directional movement of a vesicle. TL is longer than the MD of a vesicle. Circles depict the starting positions of vesicle trajectories. TL, travel length depicted as a white trajectory; MD, maximal displacement depicted as a gray line connecting the two most distant points in a vesicle trajectory. (e) Graphs represent the TL and MD of vesicles in astrocytes infected with strains ZIKV-BR, ZIKV-FP, and ZIKV-UG. TL and MD of endocytotic vesicles laden with ZIKV-BR and ZIKV-UG significantly increased with longer hpi, whereas a significant decrease was observed in endocytotic vesicles laden with ZIKV-FP. The number of vesicles analyzed is denoted on the graphs. (f) TL and MD of neuronal endocytotic vesicles laden with ZIKV strains increased at 84 versus 12 hpi. The number of vesicles analyzed is denoted on the graphs. 17-45 cells per time period and per strain were analyzed. Data were collected from one experiment performed in duplicates and are represented as means ± SEM (One Way ANOVA, *p < 0.05). (2019) 9:8069 | https://doi.org/10.1038/s41598-019-44559-8 www.nature.com/scientificreports www.nature.com/scientificreports/ 600 nm) was read on the fluorescence plate reader (Cytation 3 Cell Imaging Reader, BioTek). Each plate included several control points: wells with only medium (background), wells with non-infected cells (negative control) and cells treated with 1% Triton (positive control). To account for the background, the average RFU values of the medium-only wells were subtracted from the results. To calculate the percentage of viability, each infection time point was plotted against negative control. All experiments were performed in triplicates in two individual experiments with MOI 0.1 or MOI 1.
To monitor internalization and endocytotic vesicle mobility, DiD-labeled ZIKV strains were applied to cells at 4 °C for 10 min to synchronize virus infection and then incubated at 37 °C 70 . ZIKV was allowed to adsorb for 1 h at 37 °C or 28 °C (C6/36), then the cells were washed with PBS twice and grown in fresh growth medium.
Figure 5.
Speed of Endocytotic ZIKV-FP-Laden Vesicles Decreases the Most in Astrocytes. In astrocytes, the average speed of ZIKV-BR-and ZIKV-UG-laden vesicles significantly increased with longer hpi, whereas the speed of vesicles laden with ZIKV-FP significantly decreased. In neurons, the average vesicle speed exhibited the most prominent increase at 36 hpi, regardless of the virus strain, and then declined the most in ZIKV-FP-laden vesicles. In neuroblastoma SK-N-SH cells, the average speed of vesicles increased until 36 hpi, whereas in Vero E6 cells, the speed of virus-laden vesicles either decreased or remained unchanged. The number of analyzed cells is the same as in Figs 4, S2 and S3. Data were collected from one experiment, performed in duplicates and are represented as means ± SEM (One Way ANOVA, *p < 0.05). The average speed was calculated for the same vesicles as shown in Fig. 4. ZIKV labeling. ZIKV labeling was performed as described 36 . Briefly, ZIKV strains were grown for 4 days on Vero E6 cells. The supernatant was centrifuged twice at +4 °C (10 min at 3,200 × g and 5 min at 20,800 × g) to ensure that all cells were removed from the supernatant. The supernatant was then mixed with 50 µM fluorescent lipophilic Vybrant DiD labeling solution (DiD; Molecular Probes, Invitrogen) and incubated for 2 hr at 37 °C. The unbound dye was removed by buffer exchange into Hepes 145 buffer (50 mM Hepes, 145 mM NaCl [pH 7.4] in Illustra NAP-5 columns; GE Healthcare). The infectivity of DiD labeled viruses was verified with plaque assay (b) Graphs represent the TL and MD of vesicles in C6/36 cells infected with strains ZIKV-BR, ZIKV-FP, and ZIKV-UG. The TL and MD of vesicles remained similar at all hpi; ZIKV-BR, p = 0.081 (TL), p = 0.532 (MD); ZIKV-FP, p = 0.767 (TL), p = 0.838 (MD); ZIKV-UG, p = 0.063 (TL), p = 0.465 (MD). The number of vesicles analyzed is denoted on the graphs. 5-9 cells per time period and per strain were analyzed. Data were collected from one experiment done in duplicates and are represented as means ± SEM (One Way ANOVA, *p < 0.05).
